A dosimetric analysis of intensity-modulated radiation therapy with bone marrow sparing for cervical cancer.
Naoya Murakami(Tokushima University Hospital), Jun Itami(National Cancer Centre Japan), Hiroyuki Okamoto(Tokyo National Hospital), Takahiro Kasamatsu, Takafumi Toita(Okinawa Prefectural Chubu Hospital), Shuhei Sekii(Tokyo National Hospital), Kotaro Yoshio(Okayama University Hospital), Minako Sumi(Tokyo Metropolitan Geriatric Hospital), Koji Inaba(National Cancer Center), Mayuka Kitaguchi(Tokyo National Hospital), Ken Harada(Ibaraki University), Yoshinori Ito(National Cancer Center Hospital East), Kazuma Kobayashi(Kinki Central Hospital), Madoka Morota(Japanese Foundation For Cancer Research), Kana Takahashi(Nihon University)
PubMed
September 1, 2014
Cited by 17
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2019|2k
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2011|713
Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer
|International Journal of Clinical Oncology|2015|600
Microdosimetric Measurements and Estimation of Human Cell Survival for Heavy-Ion Beams
|Radiation Research|2006|353